In 1993 NASA scientists were trying to solve a problem.
Astronauts in microgravity were healing slowly. The weightless environment was suppressing the cellular activity that drives tissue repair.
They began testing low-level near-infrared light therapy as a way to stimulate cellular repair without pharmaceutical intervention.
What they found changed how a small group of researchers understood healing entirely.
At specific near-infrared wavelengths light penetrates past the skin surface and interacts directly with the mitochondria inside cells — the energy-producing structures in every cell in your body.
This activates an enzyme called cytochrome coxidase which accelerates ATP production and directly reduces pro-inflammatory cytokine activity in the treated tissue.
In plain English: it addresses the cellular inflammation at the source. Not by suppressing the signal. By reducing the process that produces it.
The studies were peer reviewed. NASA filed patents. Clinical research confirmed the mechanism across multiple tissue types including joint soft tissue.
And then almost nothing happened for the general public.
Not because it did not work. Because there was no way to monetize a light. You cannot patent a wavelength. You cannot charge a monthly co-pay for photons.
So it sat in research journals — used quietly in some physical therapy clinics, including mine — while millions of people kept taking ibuprofen every morning and watching their bloodwork get worse.
David deserved to know this two years before he walked into my office.
You deserve to know it now.